The global “artificial blood market” is expected to showcase considerable growth during the forecast period. The growth is attributable to the increasing number of blood transfusions and the rising incidence of hemorrhagic shock among people across the globe. This information is published by Fortune Business Insights in its upcoming report, titled, “Artificial Blood Market Size, Share& Industry Analysis, By Type (Haemoglobin-based Oxygen Carrier, Perfluorocarbon Emulsion), By Source (Animal Haemoglobin, Human Haemoglobin, Synthetic Polymer, Stem Cell, Others), By Application (Cardiovascular Diseases, Anaemia, Organ Transplant, Trauma, Others), By Distribution Channel (Hospitals, Clinics, Blood Banks, Others) and Regional Forecast 2020-2027.”
The effect of the global pandemic, COVID-19, has been felt across several economies that are facing unprecedented loss. Owing to the lockdown announced by the government agencies, several industries have been on a standstill with limited operational activities. However, a collective effort from the government as well as the industries is likely to bring the economy back on track and aid in resumption of industrial activities.
Artificial blood is a type of product that generally acts as a substitute for red blood cells. The main aim of this product is to supply oxygen, along with carbon dioxide to the body during transfusion. Additionally, they are sterilized to eliminate several viruses and bacteria and reduce the risk of contracting infectious diseases during the blood transfusion process.
Request a Sample Copy of the Research Report:
Biomedical Advancement in North America to Augment Growth
Among all the regions, North America is expected to hold the highest position in the global artificial blood market in the forthcoming years. This is attributable to the significant biomedical advancement regarding the adoption of synthetic blood in the region that will propel the adoption of artificial blood.
The market in Europe is anticipated to experience considerable growth backed by supportive government initiatives to create awareness regarding the efficacy of artificial blood products among the general population in the region between 2020 and 2027.
Investment in R&D by Key Players to Amplify Their Market Positions
The global market for artificial bloodis consolidated by major companies striving to leverage the lucrative opportunities to maintain a stronghold. These companies are focusing on investments in R&D activities to develop novel artificial blood mechanisms to cater to the growing demand from the healthcare sector. Moreover, other key players are trying to maintain their presence by adopting strategies such as collaboration, facility expansion, and the introduction of new products that will contribute to the growth of the market in the forthcoming years.
Have Any Query? Ask Our Experts:
- October 2019 – Japanese Researchers atNational Defense Medical College, announced the development of a universal artificial blood that consists of faux red blood cells and platelets in a small bag derived from cell membrane and has a shelf life of over a year. The importance of this is that it can suit the person irrespective of his blood group.
List of the Companies Profiled in the Market:
- Green Cross Corporation
- NorthField Laboratories
- Alliance Pharmaceutical Corporation
- FLUORO2 Therapeutics
- Biopure Corporation
- Alpha Therapeutics Corps
- Among others
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Related Reports :